tiprankstipranks
Trending News
More News >
Livzon Pharmaceutical Group Inc Class H (HK:1513)
:1513

Compare Livzon Pharmaceutical Group (1513) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Livzon Pharmaceutical Group
HK$30.94
HK$31.92B
11.59
11.57%
The United Laboratories International Holdings
HK$11.74
HK$23.48B
6.59
3.12%
1 Buy
0 Hold
0 Sell
Moderate Buy
China Medical System Holdings
HK$14.20
HK$34.23B
19.03
99.86%
2 Buy
1 Hold
0 Sell
Moderate Buy
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$18.75
HK$44.07B
9.58
8.58%
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$28.59B
9.50
-13.00%
Grand Pharmaceutical Group Limited
HK$7.80
HK$27.76B
13.22
85.31%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1513
Livzon Pharmaceutical Group
29.40
4.06
16.04%
HK:3933
The United Laboratories International Holdings
11.90
1.05
9.73%
HK:0867
China Medical System Holdings
14.03
7.16
104.16%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
18.98
2.02
11.93%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.55
-0.51
-10.08%
HK:0512
Grand Pharmaceutical Group Limited
7.82
3.75
92.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts